CFM
BVS icon

Comprehensive Financial Management’s Bioventus BVS Stock Holding History

Comprehensive Financial Management’s Portfolio BVS Stock Details BVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-80,838
Closed -$267K – 42
2023
Q3 		$267K Buy
+80,838
New +$284K 0.01% 42

Other funds holding BVS

EWM
Essex Woodlands Management The Woodlands, Texas $251M AUM 13.72% 1-Year Est. Return
JIC
Juniper Investment Company New York $313M AUM 79.58% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KLC
Kent Lake Capital Reno, Nevada $222M AUM 18.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

Comprehensive Financial Management's BVS Position: Q4 2023 in Review

Comprehensive Financial Management sold out of Bioventus (BVS) in Q4 2023, closing a stake of 80,838 shares — an estimated $267K sold.

Comprehensive Financial Management first reported a position in BVS in Q3 2023 and held it in 1 quarter. The position peaked at $267K in Q3 2023. 80 funds tracked by Wall St. Rank hold BVS as of Q4 2023.

  • Comprehensive Financial Management reported no remaining Bioventus position as of Q4 2023 after selling out during the quarter.
  • Comprehensive Financial Management sold 80,838 Bioventus shares in Q4 2023, an estimated $267K.
  • Comprehensive Financial Management first reported a position in Bioventus in Q3 2023 and held it in 1 quarter.
  • Comprehensive Financial Management's Bioventus position peaked at $267K in Q3 2023.
  • 80 funds tracked by Wall St. Rank held Bioventus as of Q4 2023.

Based on Comprehensive Financial Management's 13F filing for Q4 2023, filed 14 Feb 2024.